Table 2.

Sequential treatment with paclitaxel and then ALCAR does not affect the cytotoxic potential

OVCAR-3 cells	Luminescence	SD	Range		p-value
			Min	Max
ALCAR
0 μM	245,400	27,710	218,600	269,400	Control
1 μM	276,300	39,840	230,900	326,600	NA
10 μM	278,900	25,060	244,100	303,400	NA
100 μM	278,500	20,430	256,600	302,200	NA
ALCAR and Paclitaxel
0 μM	119,200	6973	111,100	127,000	Control
1 μM	104,500	8642	99,100	117,300	<.05
10 μM	107,300	6692	102,800	117,100	>.05
100 μM	100,600	5512	94,340	107,300	<.01
SKOV-3 cells
ALCAR
0 μM	246,300	81,670	126,800	310,000	Control
1 μM	267,700	12,950	253,000	282,100	NA
10 μM	278,900	3986	273,900	283,600	NA
100 μM	282,000	4147	278,400	287,000	NA
ALCAR and Paclitaxel
0 μM	96,620	7553	90,340	107,600	Control
1 μM	103,500	6833	95,770	112,200	>.05
10 μM	106,300	7939	98,250	116,600	>.05
100 μM	84,050	7760	74,690	93,000	>.05

SD—standard deviation; Min—minimum value; Max—maximum value; NA—not available {ANOVA indicated no significant difference}.